Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
ARKG ETF — ARK Genomic Revolution ETF
ARK Genomic Revolution ETF (ARKG)
Updated November 6, 2026.
ARKG is an ETF. Its expense ratio is 0.75%. Total return is 139.7% over the past 12 years, 203.9 points behind SPY at 343.6%.
ARK Genomic Revolution ETF is an actively managed ETF that invests primarily in domestic and foreign companies involved in genomics, gene editing, CRISPR technology, and molecular diagnostics across healthcare, information technology, materials, energy, and consumer discretionary sectors. The fund does not currently distribute income to shareholders and carries an expense ratio of 0.75%. It appeals to growth-oriented investors seeking exposure to genomic innovation rather than current income.
ARKG dividend yield and income
Price as of 2026-11-06.
The ex-dividend date is 12/29/2021. The payment date is 12/31/2021.
| Ex-date | Amount | Change from previous payment |
|---|---|---|
| 2021-12-29 | $0.382 | -51.6% Total cash (unclassified) |
| 2020-12-29 | $0.79 | -25.0% Total cash (unclassified) |
| 2019-12-27 | $1.054 | 126.2% Total cash (unclassified) |
| 2018-12-27 | $0.466 | 42.1% Total cash (unclassified) |
| 2017-12-27 | $0.328 | — |
| 2017 total | $0.328 | — |
| 2018 total | $0.466 | 42.1% |
| 2019 total | $1.054 | 126.2% |
| 2020 total | $0.79 | -25.0% |
| 2021 total | $0.382 | -51.6% |
ARKG dividend growth
Trailing-12-month distributions versus the preceding 12 months changed -51.6%. The 1Y row below uses this same adjacent TTM cash-window comparison.
| Window | Change |
|---|---|
| 1Y | -51.6% |
| 3Y | -18.0% |
ARKG holdings and sector exposure
The top 10 holdings are 58.6% of the fund.
| Ticker | Name | Weight |
|---|---|---|
| TEM | Tempus AI, Inc. Class A Common Stock | 9.64% |
| TXG | 10X Genomics Inc | 7.20% |
| TWST | Twist Bioscience Corp | 7.09% |
| CRSP | Crispr Therapeutics AG | 5.63% |
| GH | Guardant Health Inc | 5.35% |
| ABSI | Absci Corp | 5.26% |
| NTRA | Natera Inc | 4.88% |
| CDNA | CareDx Inc | 4.64% |
| LLY | Eli Lilly and Company | 4.52% |
| ILMN | Illumina Inc | 4.42% |
To see how this fund's sectors add up across your own holdings, use True Exposure.
ARKG performance versus SPY
Total return is 139.7% over the past 12 years, 203.9 points behind SPY at 343.6%. Over the past year its total return — price change plus distributions reinvested — is 50.0%. Its deepest 1-year drawdown was 27.5%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -21.4% | — |
| 3M | 8.2% | — |
| 6M | 49.8% | — |
| YTD | 54.0% | — |
| 1Y | 50.0% | — |
| 2Y CAGR | — | 34.20% |
| 3Y CAGR | — | 19.60% |
| 5Y CAGR | — | -10.40% |
| 10Y CAGR | — | 11.80% |
| Since inception 2014-10-31 · 12 years | 139.7% | 7.60% |
ARKG key facts
- Issuer
- ARK Invest
- Asset type
- ETF
- Asset class
- Equity
- Inception date
- 10/31/2014
- Expense ratio
- 0.75%
- Distribution frequency
- None
- Last close
- $45.45 (as of 2026-11-06)
- AUM
- $2,146,511,548
- Average volume
- 4,007,232
- Ex-dividend date
- 12/29/2021
- Payment date
- 12/31/2021
- Beta
- 2.21
How Dividend Vision calculates returns
Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: ARK Invest; prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
ARKG risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 27.5%.
Who may consider ARKG — and who may not
It is a weaker fit for investors who need monthly cash flow (ARKG does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on ARKG
Compare ARKG
ARKG vs similar funds:
Frequently asked questions
Does ARKG pay monthly?
No. ARKG does not currently distribute.
What is ARKG's expense ratio?
ARKG's expense ratio is 0.75%.
How has ARKG's dividend grown?
Trailing-12-month distributions versus the preceding 12 months changed -51.6%. That is the same adjacent TTM cash-window comparison used in the dividend-history table.
When does ARKG pay a dividend?
ARKG does not currently distribute. The ex-dividend date is 12/29/2021. The payment date is 12/31/2021.
How has ARKG performed?
Total return is 139.7% over the past 12 years, 203.9 points behind SPY at 343.6%. Over the past year its total return — price change plus distributions reinvested — is 50.0%. Its deepest 1-year drawdown was 27.5%.
More securities from ARK Invest.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.